Financials

Discussions Technicals Seasonals

048530 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

iNtRON Biotechnology, Inc. engages in the development of new biopharmaceuticals, alternatives to antibiotics for animals, and molecular diagnosis. It operates through the New Testament Part and DR Part business divisions. The company was founded on January 18, 1999 and is headquartered in Seongnam-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

048530 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company